Informace o publikaci

The Prognostic Impact of Myocardial Late Gadolinium Enhancement

Autoři

PANOVSKÝ Roman PLEVA Martin FEITOVÁ Věra KRUŽLIAK Peter MELUZÍN Jaroslav KINCL Vladimír

Rok publikování 2014
Druh Článek v odborném periodiku
Časopis / Zdroj CARDIOLOGY IN REVIEW
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Doi http://dx.doi.org/10.1097/CRD.0000000000000002
Obor Kardiovaskulární nemoci včetně kardiochirurgie
Klíčová slova cardiovascular magnetic resonance; prognosis; late gadolinium enhancement
Popis Cardiovascular magnetic resonance using late gadolinium enhancement (LGE) provides a unique opportunity to assess myocardial tissue in vivo. LGE enables tissue characterization in ischemic and nonischemic cardiomyopathies and other cardiac diseases. LGE is associated with adverse clinical outcomes across a range of different cardiac conditions and may improve risk stratification for death, sudden cardiac death, or serious adverse events beyond traditional prognostic markers. Generally, matching data for the prognostic impact of LGE are frequently reached in cardiac disorders. In other diseases, only a limited number of trials are available, but it is anticipated that the prognostic impact of delayed enhancement will become evident. The development and validation of new cardiovascular magnetic resonance methods for diffuse myocardial fibrosis measurements would even improve the prognostic impact of LGE. The evaluation of diffuse myocardial fibrosis has a great potential in large-scale diseases, including their initial phases, with the possibility to identify patients at risk for subsequent development of clinical heart failure, to assess repeatedly the stage and progression of cardiac diseases, and to monitor the effect of treatment.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info